HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 2,377-2,388 of 7,264
Behavioral study icon
CompletedNCT00149110

Chronos: the Use of Chronobiological Treatment in Depression

Official study title

"The CHRONOS Study: Can the Sleep-deprivation Induced Antidepressive Effect in Patients With Major Depression be Sustained by Correction of Diurnal Rhythms, Long Term Light Treatment and Duloxetine Treatment?"

This study has finished and is no longer accepting participants.

In Hilleroed
DepressionMedication studyAges 18–70
Countries
Denmark
Sponsor
Hillerod Hospital, Denmark
Other study type icon
CompletedNCT00844974

Cognitive Deficits in Major Depressive Disorder and Bipolarity, Depressed Type: Prevalence and Improvement With Treatment of Depressive Symptoms

Official study title

Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder Depressed Type: Prevalence and Symptoms With Treating of Depressive Symptoms

This study has finished and is no longer accepting participants.

In Boston
Depression, BipolarityInterventional studyAges 18+
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Biological study icon
CompletedNCT07062783

Effect of Aerobic Exercise on Biomarkers in Depression

Official study title

The Effect of Respiratory and Aerobic Exercises on Neuroprotective and Inflammation Biomarkers in Patients Diagnosed With Major Depression

This study has finished and is no longer accepting participants.

In Kütahya
DepressionInterventional studyAges 18–40
Countries
Türkiye
Sponsor
Kutahya Health Sciences University
Drug study icon
CompletedNCT06278038

Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets for depression

What is this study about?

This study evaluated the safety and effectiveness of Toludesvenlafaxine hydrochloride sustained-release tablets for people with depression.

This study has finished and is no longer accepting participants.

In Hangzhou
DepressionMedication studyAges 18–65
Countries
China
Sponsor
First Affiliated Hospital of Zhejiang University
Device study icon
TerminatedNCT01842542

NeuroStar TMS Therapy for depression

Official study title

An Open-Label Study to Evaluate the Efficacy and Safety of the Neuronetics NeuroStar TMS Therapy System in Patients With Major Depressive Disorder (MDD) With Postpartum Onset.

This study ended early.

Multiple locations, including Hartford
DepressionDevice studyAges 18–50
Countries
United States
Sponsor
Neuronetics
Drug study icon
CompletedNCT06963580

Efficacy of MI078 Capsules in Treating Postpartum Depression

Official study title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of MI078 Capsule in Patients With Postpartum Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Wuhu
DepressionMedication studyAges 18–45
Countries
China
Sponsor
Nanjing Minova Pharmaceutical Co., Ltd.
Drug study icon
CompletedNCT02285504

Evaluate SAGE-547 in Female people with Severe Postpartum Depression

What is this study about?

This study evaluated the safety and effectiveness of SAGE-547 for people with depression.

This study has finished and is no longer accepting participants.

In Chapel Hill
DepressionMedication studyAges 18–45
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.